Rely+On Virkon from LANXESS effective against monkeypox virus
- Effectiveness of Rely+On Virkon scientifically proven
- Disinfection a key to help prevent transmission
- Hygiene best practices essential
With cases of monkeypox continuing to rise and spread around the world, government health departments are providing advice and guidance on how to help prevent transmission of the disease with hygiene and disinfection of the utmost importance.
The high level disinfectant Rely+On Virkon from specialty chemicals company LANXESS is effective against the monkeypox virus. The product is used for hard surface disinfection in hospital, healthcare and institutional facilities, airports, public transport terminals, clinics, shopping malls and many other routes of transition. Francois Martignoni, Head of the Human Health Disinfectants Business at LANXESS: “Practicing good hygiene must always be a part of our everyday routines, but the selection of a disinfectant proven to kill the target pathogen is critical”.
Rely+On Virkon inactivates monkeypox virus quickly
Independent tests have proven that Rely+On Virkon inactivates a closely related surrogate of the currently spreading pox virus strain. “From these tests it can be concluded that Rely+On Virkon is also effective against monkeypox virus,” Martignoni said.
Rely+On Virkon achieved inactivation of the pox virus strain at a 1:100 dilution rate with a 15-minute contact time. This corresponds to test conditions set out by the French AFNOR Association and proves the performance and suitability of Rely+On Virkon for practical use.
Rely+On Virkon is diluted for application and sprayed on hard surfaces. It can therefore help to reduce the risk of cross-contamination.
LANXESS’ Material Protection Products business unit produces a wide range of scientifically based biocide technologies under the Virkon brand. Further information can be found at www.relyondisinfection.com.
Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.
Information for editors:
All global LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com.
Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.
